Brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma (HL): North American results Meeting Abstract
| Authors: | Ramchandren, R.; Advani, R. H.; Ansell, S. M.; Bartlett, N. L.; Chen, R. W.; Feldman, T.; Forero-Torres, A.; Friedberg, J. W.; Gopal, A. K.; Gordon, L. I.; Kuruvilla, J.; Savage, K. J.; Straus, D. J.; Younes, A.; Fenton, K.; Manley, T. J.; Engley, G.; Connors, J. M. |
| Abstract Title: | Brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma (HL): North American results |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 410s |
| Language: | English |
| ACCESSION: | WOS:000442916003007 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.7541 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7541 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
